Ketamine, psilocybin and other psychedelics are being tested for alcohol use disorder, depression and other conditions linked to addiction. This session reviews clinical evidence, safety, integration therapy and how ketamine-assisted treatment fits into wider care models.
Topics include: ketamine-assisted psychotherapy, psilocybin for alcohol use disorder, mechanisms of action, memory and cognition, safety and abuse liability, integrated treatment models.